CLMP
CXADR-like membrane protein
Also known as: ACAM, ASAM, CLMP_HUMAN, FLJ22415
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H6B4
- Gene
- CLMP
- Ensembl
- ENSG00000166250
- Chromosome
- 11
- Canonical length
- 373 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a type I transmembrane protein that is localized to junctional complexes between endothelial and epithelial cells and may have a role in cell-cell adhesion. Expression of this gene in white adipose tissue is implicated in adipocyte maturation and development of obesity. This gene is also essential for normal intestinal development and mutations in the gene are associated with congenital short bowel syndrome. [provided by RefSeq, Aug 2015]
Canonical amino-acid sequenceUniProt
373 residues, UniProt reviewed canonical sequence.
>Q9H6B4|CLMP
1 MSLLLLLLLV SYYVGTLGTH TEIKRVAEEK VTLPCHHQLG LPEKDTLDIE WLLTDNEGNQ
61 KVVITYSSRH VYNNLTEEQK GRVAFASNFL AGDASLQIEP LKPSDEGRYT CKVKNSGRYV
121 WSHVILKVLV RPSKPKCELE GELTEGSDLT LQCESSSGTE PIVYYWQRIR EKEGEDERLP
181 PKSRIDYNHP GRVLLQNLTM SYSGLYQCTA GNEAGKESCV VRVTVQYVQS IGMVAGAVTG
241 IVAGALLIFL LVWLLIRRKD KERYEEEERP NEIREDAEAP KARLVKPSSS SSGSRSSRSG
301 SSSTRSTANS ASRSQRTLST DAAPQPGLAT QAYSLVGPEV RGSEPKKVHH ANLTKAETTP
361 SMIPSQSRAF QTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLMP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 59 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 59 nTPM
- blood vessel: 44 nTPM
- colon: 39 nTPM
- smooth muscle: 34 nTPM
- endometrium: 28 nTPM
- placenta: 25 nTPM
Single-cell type
- adipocytes: 524 nCPM
- endometrial stromal cells: 248 nCPM
- fibroblasts: 235 nCPM
- myosatellite cells: 234 nCPM
- fibro-adipogenic progenitors: 231 nCPM
- decidual stromal cells: 169 nCPM
Immune cell
- neutrophil: 0.5 nTPM
- basophil: 0.3 nTPM
- MAIT T-cell: 0.2 nTPM
- memory CD4 T-cell: 0.2 nTPM
- naive B-cell: 0.2 nTPM
- classical monocyte: 0.1 nTPM
Brain region
- cerebellum: 20 nTPM
- hippocampal formation: 15 nTPM
- white matter: 15 nTPM
- medulla oblongata: 13 nTPM
- choroid plexus: 11 nTPM
- cerebral cortex: 9.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CLMP.
Disease | AllUniProt
Conditions CLMP is implicated in, by any mechanism.
- Congenital short bowel syndrome (CSBS) MIM:615237
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 72 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital short bowel syndrome, autosomal recessive
- Intestinal pseudo-obstruction
- Congenital short bowel syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.58
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLMP as an antibody target. Whether an autoantibody or antibody against CLMP could matter depends on whether native CLMP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLMP is annotated at the cell surface, where native CLMP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CLMP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...